Correlation Between Roivant Sciences and EFFECTOR Therapeutics
Can any of the company-specific risk be diversified away by investing in both Roivant Sciences and EFFECTOR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Roivant Sciences and EFFECTOR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Roivant Sciences and EFFECTOR Therapeutics, you can compare the effects of market volatilities on Roivant Sciences and EFFECTOR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Roivant Sciences with a short position of EFFECTOR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Roivant Sciences and EFFECTOR Therapeutics.
Diversification Opportunities for Roivant Sciences and EFFECTOR Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Roivant and EFFECTOR is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Roivant Sciences and EFFECTOR Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on EFFECTOR Therapeutics and Roivant Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Roivant Sciences are associated (or correlated) with EFFECTOR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of EFFECTOR Therapeutics has no effect on the direction of Roivant Sciences i.e., Roivant Sciences and EFFECTOR Therapeutics go up and down completely randomly.
Pair Corralation between Roivant Sciences and EFFECTOR Therapeutics
Given the investment horizon of 90 days Roivant Sciences is expected to generate 50.94 times less return on investment than EFFECTOR Therapeutics. But when comparing it to its historical volatility, Roivant Sciences is 22.07 times less risky than EFFECTOR Therapeutics. It trades about 0.03 of its potential returns per unit of risk. EFFECTOR Therapeutics is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 14.00 in EFFECTOR Therapeutics on November 5, 2024 and sell it today you would lose (13.90) from holding EFFECTOR Therapeutics or give up 99.29% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 55.06% |
| Values | Daily Returns |
Roivant Sciences vs. EFFECTOR Therapeutics
Performance |
| Timeline |
| Roivant Sciences |
| EFFECTOR Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Roivant Sciences and EFFECTOR Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Roivant Sciences and EFFECTOR Therapeutics
The main advantage of trading using opposite Roivant Sciences and EFFECTOR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Roivant Sciences position performs unexpectedly, EFFECTOR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EFFECTOR Therapeutics will offset losses from the drop in EFFECTOR Therapeutics' long position.| Roivant Sciences vs. Krystal Biotech | Roivant Sciences vs. Akero Therapeutics | Roivant Sciences vs. Apellis Pharmaceuticals | Roivant Sciences vs. Day One Biopharmaceuticals |
| EFFECTOR Therapeutics vs. Celularity | EFFECTOR Therapeutics vs. Humacyte | EFFECTOR Therapeutics vs. NRx Pharmaceuticals | EFFECTOR Therapeutics vs. Reviva Pharmaceuticals Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |